• Home
  • News
  • IPOS Member Profile: Cristina Salgado Blanco (Spain)

IPOS Member Profile: Cristina Salgado Blanco (Spain)

12 Jan 2024 9:22 AM | John Chagnon (Administrator)

I am currently investigating depressive symptoms and cognitive impairments (memory problems, attention, mental agility...) associated with breast cancer. Specifically, I am studying possible biomarkers of both conditions and a home treatment that combines non-invasive brain stimulation techniques and cognitive training to improve these symptoms (NCT06053775). I became a member of IPOS because I believe that it will greatly contribute to enrich my professional practice, both clinical practice and research, by meeting professionals in this field and being up to date in therapeutic intervention with oncology patients. In addition, I believe that this membership will allow me to disseminate my work so that other professionals can get to know it. I have initiated this research project with the intention of learning more about one of the main sequelae of cancer, which often goes unnoticed by medical professionals and for which many patients do not receive treatment. I hope to be able to extend this knowledge to other populations, such as children, to improve the quality of life of these patients. I am confident that my background and enthusiasm will make this possible!

Interested in being profiled?

Please email the following to [email protected] with the subject line “IPOS member profile submission”:

  1. Name
  2. Employment position
  3. Employer/Institution
  4. Country
  5. Twitter handle (if available)
  6. Jpg photo of yourself
  7. 50-to-200-word description that notes details on your practice, involvement with IPOS and something “fun or interesting” about yourself.

International Psycho-Oncology Society
1 - 189 Queen Street East
Toronto, ON M5A 1S2

244 Fifth Avenue, Suite L296
New York, NY 10001

T: +1 416-968-0260
[email protected]

Follow IPOS

© 2024 International Psycho-Oncology Society 

 Website powered by Funnel Communications Inc.